Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (231-240 of 953) with videos related to

Pageof 96
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Microbleeds are associated with depressive symptoms in Alzheimer's diseaseAnna E Leeuwis, Niels D Prins, Astrid M Hooghiemstra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 8, 2009
Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel diseaseSalka S Staekenborg, Tanja Su, Elisabeth C W van Straaten, et al.
Alzheimer'S Research & Therapy|January 27, 2018
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's diseaseFlora H Duits, Gunnar Brinkmalm, Charlotte E Teunissen, et al.
Neurobiology of Aging|June 25, 2017
EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjectsAlida A Gouw, Astrid M Alsema, Betty M Tijms, et al.
Alzheimer'S Research & Therapy|June 8, 2017
Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patientsClaire Bridel, Torsten Hoffmann, Antje Meyer, et al.
Frontiers in Human Neuroscience|June 1, 2016
Slowing of Hippocampal Activity Correlates with Cognitive Decline in Early Onset Alzheimer's Disease. An MEG Study with Virtual ElectrodesMarjolein M A Engels, Arjan Hillebrand, Wiesje M van der Flier, et al.
Neurobiology of Aging|March 21, 2017
Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development frameworkMara Ten Kate, Frederik Barkhof, Marina Boccardi, et al.
Lancet (London, England)|March 5, 2021
Alzheimer's diseasePhilip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
Alzheimer'S Research & Therapy|September 14, 2017
Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairmentMara Ten Kate, Frederik Barkhof, Pieter Jelle Visser, et al.
Neurobiology of Aging|April 2, 2008
Inflammatory markers in AD and MCI patients with different biomarker profilesAlie Schuitemaker, Miranda G Dik, Robert Veerhuis, et al.
Pageof 96

Showing results (231-240 of 953) with videos related to

Sort By:
Pageof 96
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Microbleeds are associated with depressive symptoms in Alzheimer's diseaseAnna E Leeuwis, Niels D Prins, Astrid M Hooghiemstra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 8, 2009
Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel diseaseSalka S Staekenborg, Tanja Su, Elisabeth C W van Straaten, et al.
Alzheimer'S Research & Therapy|January 27, 2018
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's diseaseFlora H Duits, Gunnar Brinkmalm, Charlotte E Teunissen, et al.
Neurobiology of Aging|June 25, 2017
EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjectsAlida A Gouw, Astrid M Alsema, Betty M Tijms, et al.
Alzheimer'S Research & Therapy|June 8, 2017
Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patientsClaire Bridel, Torsten Hoffmann, Antje Meyer, et al.
Frontiers in Human Neuroscience|June 1, 2016
Slowing of Hippocampal Activity Correlates with Cognitive Decline in Early Onset Alzheimer's Disease. An MEG Study with Virtual ElectrodesMarjolein M A Engels, Arjan Hillebrand, Wiesje M van der Flier, et al.
Neurobiology of Aging|March 21, 2017
Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development frameworkMara Ten Kate, Frederik Barkhof, Marina Boccardi, et al.
Lancet (London, England)|March 5, 2021
Alzheimer's diseasePhilip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
Alzheimer'S Research & Therapy|September 14, 2017
Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairmentMara Ten Kate, Frederik Barkhof, Pieter Jelle Visser, et al.
Neurobiology of Aging|April 2, 2008
Inflammatory markers in AD and MCI patients with different biomarker profilesAlie Schuitemaker, Miranda G Dik, Robert Veerhuis, et al.
Pageof 96